Table of Contents Author Guidelines Submit a Manuscript
Journal of Environmental and Public Health
Volume 2018, Article ID 3180487, 10 pages
https://doi.org/10.1155/2018/3180487
Research Article

Long-Term Effects of Environmental Lead Exposure on Blood Pressure and Plasma Soluble Cell Adhesion Molecules in Young Adults: A Follow-Up Study of a Prospective Cohort in Kosovo

1Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York City, NY, USA
2Medical Center, Mitrovica, Kosovo
3Medical Faculty, University of Prishtina, Prishtina, Kosovo
4Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City, NY, USA

Correspondence should be addressed to Pam Factor-Litvak; ude.aibmuloc@1frp

Received 27 June 2017; Accepted 15 November 2017; Published 8 January 2018

Academic Editor: Linda M. Gerber

Copyright © 2018 Pashko R. Camaj et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Lustberg and E. Silbergeld, “Blood lead levels and mortality,” JAMA Internal Medicine, vol. 162, no. 21, pp. 2443–2449, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Muntner, A. Menke, K. B. DeSalvo, F. A. Rabito, and V. Batuman, “Continued decline in blood lead levels among adults in the United States: The national health and nutrition examination surveys,” JAMA Internal Medicine, vol. 165, no. 18, pp. 2155–2161, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. J. L. Pirkle, J. Schwartz, J. R. Landis, and W. R. Harlan, “The relationship between blood lead levels and blood pressure and its cardiovascular risk implications,” American Journal of Epidemiology, vol. 121, no. 2, pp. 246–258, 1985. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Menke, P. Muntner, V. Batuman, E. K. Silbergeld, and E. Guallar, “Blood lead below 0.48 μmol/L (10 μg/dL) and mortality among US adults,” Circulation, vol. 114, no. 13, pp. 1388–1394, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Navas-Acien, E. Guallar, E. K. Silbergeld, and S. J. Rothenberg, “Lead exposure and cardiovascular disease: a systematic review,” Environmental Health Perspectives, vol. 115, no. 3, pp. 472–482, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Nash, L. Magder, M. Lustberg et al., “Blood lead, blood pressure, and hypertension in perimenopausal and postmenopausal women,” The Journal of the American Medical Association, vol. 289, no. 12, pp. 1523–1532, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Vupputuri, J. He, P. Muntner, L. A. Bazzano, P. K. Whelton, and V. Batuman, “Blood lead level is associated with elevated blood pressure in blacks,” Hypertension, vol. 41, no. 3 I, pp. 463–468, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. B. S. Glenn, W. F. Stewart, J. M. Links, A. C. Todd, and B. S. Schwartz, “The longitudinal association of lead with blood pressure,” Epidemiology, vol. 14, no. 1, pp. 30–36, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. D. S. Sharp, C. E. Becker, and A. H. Smith, “Chronic Low-Level Lead Exposure: Its Role in the Pathogenesis of Hypertension,” Medical Toxicology and Adverse Drug Experience, vol. 2, no. 3, pp. 210–232, 1987. View at Publisher · View at Google Scholar · View at Scopus
  10. I. Hertz-Picciotto and J. Croft, “Review of the relation between blood lead and blood pressure,” Epidemiologic Reviews, vol. 15, no. 2, pp. 352–373, 1993. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Schwartz, “Lead, blood pressure, and cardiovascular disease in men and women,” Environmental Health Perspectives, vol. 91, pp. 71–75, 1991. View at Publisher · View at Google Scholar
  12. J. A. Staessen, C. J. Bulpitt, R. Fagard et al., “Hypertension caused by low-level lead exposure: Myth or fact?” European Journal of Cardiovascular Prevention & Rehabilitation, vol. 1, no. 1, pp. 87–97, 1994. View at Publisher · View at Google Scholar · View at Scopus
  13. J. A. Staessen, H. Roels, and R. Fagard, “Lead exposure and conventional and ambulatory blood pressure: A prospective population study,” Journal of the American Medical Association, vol. 275, no. 20, pp. 1563–1570, 1996. View at Publisher · View at Google Scholar · View at Scopus
  14. T. S. Nawrot, L. Thijs, E. M. Den Hond, H. A. Roels, and J. A. Staessen, “An epidemiological re-appraisal of the association between blood pressure and blood lead: A meta-analysis,” Journal of Human Hypertension, vol. 16, no. 2, pp. 123–131, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. U. S. EPA, “Integrated Science Assessment (ISA) for Lead,” Tech. Rep., U.S. Environmental Protection Agency, Washington, DC, USA, EPA/600/R-10/075F, July 2013. View at Google Scholar
  16. F. Scinicariello, A. Yesupriya, M. Chang, and B. A. Fowler, “Modification by ALAD of the association between blood lead and blood pressure in the U.S. population: results from the third national health and nutrition examination survey,” Environmental Health Perspectives, vol. 118, no. 2, pp. 259–264, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. S. M. Selbst, R. K. Sokas, F. M. Henretig, S. C. Weller, and A. M. Tershakovec, “The effect of blood lead on blood pressure in children,” Journal of Environ. Pathol. Toxicol. Oncology, vol. 12, no. 4, pp. 213–218, 1993. View at Google Scholar
  18. B. B. Gump, P. Stewart, J. Reihman et al., “Prenatal and early childhood blood lead levels and cardiovascular functioning in 91/2 year old children,” Neurotoxicology and Teratology, vol. 27, no. 4, pp. 655–665, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Zhang, H. Hu, B. N. Sánchez et al., “Association between prenatal lead exposure and blood pressure in children,” Environmental Health Perspectives, vol. 120, no. 3, pp. 445–450, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Factor-Litvak, J. K. Kline, D. Popovac et al., “Blood lead and blood pressure in young children,” Epidemiology, vol. 7, no. 6, pp. 633–637, 1996. View at Publisher · View at Google Scholar · View at Scopus
  21. A. D. Blann, S. K. Nadar, and G. Y. H. Lip, “The adhesion molecule P-selectin and cardiovascular disease,” European Heart Journal, vol. 24, no. 24, pp. 2166–2179, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. L. E. P. Rohde, C. H. Hennekens, and P. M. Ridker, “Cross-sectional study of soluble intercellular adhesion molecule-1 and cardiovascular risk factors in apparently healthy men,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 7, pp. 1595–1599, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. C. U. Chae, R. T. Lee, N. Rifai, and P. M. Ridker, “Blood pressure and inflammation in apparently healthy men,” Hypertension, vol. 38, no. 3, pp. 399–403, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Factor-Litvak, G. Wasserman, J. K. Kline, and J. Graziano, “The Yugoslavia Prospective Study of environmental lead exposure,” Environmental Health Perspectives, vol. 107, no. 1, pp. 9–15, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. P. R. Camaj, Long-term consequences of environmental lead exposure in Kosovo: effects of pre and postnatal lead exposure in early adulthood [Dissertation, thesis], Columbia University Dissertation, 2013, http://pqdtopen.proquest.com/doc/1500560168.html.
  26. E. D. Frohlich, “Update: Recommendations for human blood pressure determination by sphygmomanometers (Reply),” Hypertension, vol. 16, no. 5, p. 594, 1990. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Mancia, G. Grassi, G. Pomidossi et al., “Effects of blood-pressure measurement by the doctor on patient's blood pressure and heart rate,” The Lancet, vol. 322, no. 8352, pp. 695–698, 1983. View at Publisher · View at Google Scholar · View at Scopus
  28. T. G. Pickering, G. D. James, C. Boddie, G. A. Harshfield, S. Blank, and J. H. Laragh, “How common is white coat hypertension?” The Journal of the American Medical Association, vol. 259, no. 2, pp. 225–228, 1988. View at Publisher · View at Google Scholar · View at Scopus
  29. F. Fernandez and Hilligoss, “An improved graphite furnace method for the determination of lead in bloos using matrix modification and L’vov platform,” Atomic Spectroscopomet, vol. 3, pp. 130-131, 1982. View at Google Scholar
  30. E. Den Hond, T. Nawrot, and J. A. Staessen, “The relationship between blood pressure and blood lead in NHANES III,” Journal of Human Hypertension, vol. 16, no. 8, pp. 563–568, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. W. R. Harlan, “The relationship of blood lead levels to blood pressure in the U.S. population,” Environmental Health Perspectives, vol. 78, pp. 9–13, 1988. View at Publisher · View at Google Scholar · View at Scopus
  32. J. R. Landis and K. M. Flegal, “A generalized Mantel-Haenszel analysis of the regression of blood pressure on blood lead using NHANES II data,” Environmental Health Perspectives, vol. 78, pp. 35–41, 1988. View at Publisher · View at Google Scholar · View at Scopus
  33. D. Karasek, H. Vaverkova, M. Halenka, M. Budikova, and D. Novotny, “Soluble cell adhesion molecules s-vcam-1 and s-icam-1 in subjects with familial combined hyperlipidemia,” Biomedical Papers, vol. 149, no. 1, pp. 101–108, 2005. View at Publisher · View at Google Scholar
  34. K. K. Shalia, M. R. Mashru, J. B. Vasvani, R. A. Mokal, S. M. Mithbawkar, and P. K. Thakur, “Circulating levels of cell adhesion molecules in hypertension,” Indian Journal of Clinical Biochemistry, vol. 24, no. 4, pp. 388–397, 2009. View at Publisher · View at Google Scholar
  35. S. J. Pocock, A. G. Shaper, D. Ashby, H. T. Delves, and B. E. Clayton, “The relationship between blood lead, blood pressure, stroke, and heart attacks in middle-aged British men,” Environmental Health Perspectives, vol. 78, pp. 23–30, 1988. View at Publisher · View at Google Scholar · View at Scopus
  36. P. C. Elwood, J. W. G. Yarnell, P. D. Oldham et al., “Blood pressure and blood lead in surveys in wales,” American Journal of Epidemiology, vol. 127, no. 5, pp. 942–945, 1988. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Factor-Litvak, Z. Stein, and J. Graziano, “Increased risk of proteinuria among a cohort of lead-exposed pregnant women,” Environmental Health Perspectives, vol. 101, no. 5, pp. 418–421, 1993. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Cheng, J. Schwartz, D. Sparrow, A. Aro, S. T. Weiss, and H. Hu, “Bone lead and blood lead levels in relation to baseline blood pressure and the prospective development of hypertension. The normative aging study,” American Journal of Epidemiology, vol. 153, no. 2, pp. 164–171, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. H. Hu, “The relationship of bone and blood lead to hypertensionL: the normative aging study,” Journal of the American Medical Association, vol. 275, no. 15, p. 1171, 1996. View at Publisher · View at Google Scholar
  40. A. Chen, G. G. Rhoads, B. Cai, M. Salganik, and W. J. Rogan, “The effect of chelation on blood pressure in lead-exposed children: A randomized study,” Environmental Health Perspectives, vol. 114, no. 4, pp. 579–583, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. A. J. Vander, “Chronic effects of lead on the renin-angiotensin system,” Environmental Health Perspectives, vol. 78, pp. 77–83, 1988. View at Publisher · View at Google Scholar · View at Scopus
  42. R. Nowack, A. Wiecek, B. Exner, N. Gretz, and E. Ritz, “Chronic lead exposure in rats: effects on blood pressure,” European Journal of Clinical Investigation, vol. 23, no. 7, pp. 433–443, 1993. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Amani, N. Ali, B. Reza, and K. Ali, “Effect of ascorbic acid supplementation on nitric oxide metabolites and systolic blood pressure in rats exposed to lead,” Indian Journal of Pharmacology, vol. 42, no. 2, pp. 78–81, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. S. J. Kopp, J. T. Barron, and J. P. Tow, “Cardiovascular actions of lead and relationship to hypertension: A review,” Environmental Health Perspectives, vol. 78, pp. 91–99, 1988. View at Publisher · View at Google Scholar · View at Scopus
  45. N. D. Vaziri, K. Liang, and Y. Ding, “Increased nitric oxide inactivation by reactive oxygen species in lead- induced hypertension,” Kidney International, vol. 56, no. 4, pp. 1492–1498, 1999. View at Publisher · View at Google Scholar · View at Scopus
  46. N. Dursun, C. Arifoglu, C. Süer, and L. Keskinol, “Blood pressure relationship to nitric oxide, lipid peroxidation, renal function, and renal blood flow in rats exposed to low lead levels,” Biological Trace Element Research, vol. 104, no. 2, pp. 141–149, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. C. Fujiwara, T. Kaji, C. Yamamoto, M. Sakamoto, and H. Kozuka, “Stimulatory effect of lead on the proliferation of cultured vascular smooth-muscle cells,” Toxicology, vol. 98, no. 1-3, pp. 105–110, 1995. View at Publisher · View at Google Scholar · View at Scopus
  48. S.-J. Hwang, C. M. Ballantyne, A. R. Sharrett et al., “Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk in Communities (ARIC) study,” Circulation, vol. 96, no. 12, pp. 4219–4225, 1997. View at Publisher · View at Google Scholar · View at Scopus
  49. P. M. Ridker, C. H. Hennekens, J. E. Buring, and N. Rifai, “C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women,” The New England Journal of Medicine, vol. 342, no. 12, pp. 836–843, 2000. View at Publisher · View at Google Scholar · View at Scopus
  50. T. Krauss, G. Emons, W. Kuhn, and H. G. Augustin, “Predictive value of routine circulating soluble endothelial cell adhesion molecule measurements during pregnancy,” Clinical Chemistry, vol. 48, no. 9, pp. 1418–1425, 2002. View at Google Scholar · View at Scopus
  51. S. Blankenberg, H. J. Rupprecht, C. Bickel et al., “Circulating cell adhesion molecules and death in patients with coronary artery disease,” Circulation, vol. 104, no. 12, pp. 1336–1342, 2001. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Blankenberg, S. Barbaux, and L. Tiret, “Adhesion molecules and atherosclerosis,” Atherosclerosis, vol. 170, no. 2, pp. 191–203, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. T. M. Carlos and J. M. Harlan, “Leukocyte-endothelial adhesion molecules,” Blood, vol. 84, no. 7, pp. 2068–2101, 1994. View at Google Scholar · View at Scopus
  54. R. Ross, “The pathogenesis of atherosclerosis: a perspective for the 1990s,” Nature, vol. 362, no. 6423, pp. 801–809, 1993. View at Publisher · View at Google Scholar · View at Scopus
  55. P. J. Polverini, “Role of the macrophage in angiogenesis-dependent diseases.,” EXS, vol. 79, pp. 11–28, 1997. View at Google Scholar · View at Scopus
  56. N. Morisaki, I. Saito, K. Tamura et al., “New indices of ischemic heart disease and aging: Studies on the serum levels of soluble intercellular adhesion molecule-1 (ICAM-1) and soluble vascular cell adhesion molecule-1 (VCAM-1) in patients with hypercholesterolemia and ischemic heart disease,” Atherosclerosis, vol. 131, no. 1, pp. 43–48, 1997. View at Publisher · View at Google Scholar · View at Scopus
  57. P. M. Ridker, C. H. Hennekens, B. Roitman-Johnson, M. J. Stampfer, and J. Allen, “Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men,” The Lancet, vol. 351, no. 9096, pp. 88–92, 1998. View at Publisher · View at Google Scholar · View at Scopus
  58. G. Luc, D. Arveiler, A. Evans et al., “Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and incident coronary heart disease: the PRIME Study,” Atherosclerosis, vol. 170, no. 1, pp. 169–176, 2003. View at Publisher · View at Google Scholar · View at Scopus
  59. E. M. A. Mervaala, D. N. Müller, J.-K. Park et al., “Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension,” Hypertension, vol. 33, no. 1, pp. 389–395, 1999. View at Publisher · View at Google Scholar · View at Scopus
  60. N. Bonello and R. J. Norman, “Soluble adhesion molecules in serum throughout the menstrual cycle,” Human Reproduction, vol. 17, no. 9, pp. 2272–2278, 2002. View at Publisher · View at Google Scholar · View at Scopus
  61. V. Videm and M. Albrigtsen, “Soluble ICAM-1 and VCAM-1 as markers of endothelial activation,” Scandinavian Journal of Immunology, vol. 67, no. 5, pp. 523–531, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. “Provisional Self Government in Kosovo Ministry of Health and National Institute for Research on Food and Nutrition-Italy (UNICEF) (2002),” Micro-nutrient status Survey in Kosovo, 2002. View at Publisher · View at Google Scholar